Title |
Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts
|
---|---|
Published in |
Investigational New Drugs, November 2015
|
DOI | 10.1007/s10637-015-0303-x |
Pubmed ID | |
Authors |
Jeffrey D. Serrill, Xuemei Wan, Andrew M. Hau, Hyo Sang Jang, Daniel J. Coleman, Arup K. Indra, Adam W. G. Alani, Kerry L. McPhail, Jane E. Ishmael |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Germany | 1 | 2% |
Unknown | 55 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 17 | 30% |
Student > Master | 6 | 11% |
Researcher | 6 | 11% |
Student > Bachelor | 5 | 9% |
Professor > Associate Professor | 3 | 5% |
Other | 7 | 12% |
Unknown | 13 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 18% |
Agricultural and Biological Sciences | 9 | 16% |
Medicine and Dentistry | 8 | 14% |
Chemistry | 6 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 6 | 11% |
Unknown | 16 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2016.
All research outputs
#8,059,753
of 26,017,215 outputs
Outputs from Investigational New Drugs
#345
of 1,286 outputs
Outputs of similar age
#93,100
of 296,045 outputs
Outputs of similar age from Investigational New Drugs
#4
of 11 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,286 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 296,045 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.